Clinical trial

Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus

NCT03332836

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2017-10-25

PhasePHASE1

Study timeline

Study start (actual)2017-10-25Date precision: day

Registry last updated2021-04-01

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetes Mellitusunresolved

Interventions

HM12460ABIOLOGICAL

Sponsors & collaborators

Hanmi Pharmaceutical Company Limitedlead sponsor

Mapped research locations

Chula VistaCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03332836 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.